000			01597 a2200445 4500
005			20250517020740.0
264		0	_c20150706
008			201507s 0 0 eng d
022			_a1090-2430
024	7		_a10.1016/j.expneurol.2015.02.028 _2doi
040			_aNLM _beng _cNLM
100	1		_aMondello, S E
245	0	0	_aImpact of treatment duration and lesion size on effectiveness of chondroitinase treatment post-SCI. _h[electronic resource]
260			_bExperimental neurology _cMay 2015
300			_a64-77 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBrain _xdrug effects
650	0	4	_aCats
650	0	4	_aChondroitin ABC Lyase _xmetabolism
650	0	4	_aConditioning, Operant _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aFemale
650	0	4	_aFunctional Laterality
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aMyelin Sheath _xpathology
650	0	4	_aPsychomotor Performance
650	0	4	_aRecovery of Function _xdrug effects
650	0	4	_aRespiration Disorders _xdrug therapy
650	0	4	_aSpinal Cord Injuries _xcomplications
650	0	4	_aStatistics, Nonparametric
650	0	4	_aStilbamidines
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aJefferson, S C
700	1		_aTester, N J
700	1		_aHowland, D R
773	0		_tExperimental neurology _gvol. 267 _gp. 64-77
856	4	0	_uhttps://doi.org/10.1016/j.expneurol.2015.02.028 _zAvailable from publisher's website
999			_c24663670 _d24663670